Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers

New publication on Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers from Transfusion and Apheresis Science

#vascularaccess #FOAMva #FOAMed #FOAMem #FOAMcc #FOAMems

Leave a Reply Cancel reply

Enter your comment here...

Please log in using one of these methods to post your comment:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

Mid-thigh cannulation of the superficial femoral vein January 19, 2020
The technique of femoral inserted central catheters insertion via the superficial femoral vein at the mid-thigh has a high success rate, low complication rate, and less impact on activities, and is easy to maintain” Zhao et al (2019). Abstract: PURPOSE: Patients needing medium- to long-term infusion therapy with limited catheterization via the superior vena […]
IVTEAM
Effect of cold and hot compress on the site of doxorubicin extravasation January 19, 2020
In the present study, we investigated a part of the mechanism responsible for the effects of hot and cold compresses for extravasation of doxorubicin” Miura et al (2019). Abstract: In the present study, we investigated a part of the mechanism responsible for the effects of hot and cold compresses for extravasation of doxorubicin. We injected [...] The post E […]
IVTEAM
Differences in CLABSI rates based on central line days January 19, 2020
Central line–associated bloodstream infection (CLABSI) rates are an important quality performance indicator associated with patient morbidity, mortality, and increased costs” Scheinker et al (2020). Abstract: Central line–associated bloodstream infection (CLABSI) rates are an important quality performance indicator associated with patient morbidity, mortalit […]
IVTEAM
Risk factors for PICC complications in neonates January 19, 2020
Approximately one-third of PICCs were associated with complications. When feasible, lower extremity PICCs should be placed as they may be associated with fewer complications” Pet et al (2020). Abstract: OBJECTIVE: To determine factors associated with nonelective PICC removal and complications. STUDY DESIGN: Overall, 1234 PICCs were placed in 918 hospitalized […]
IVTEAM
FUSION IV Pharmaceuticals issues voluntary nationwide recall of all sterile drug products January 19, 2020
FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry” FDA (2019). FDA report “FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry, to the user level, due to a lack of assurance of sterility. The recalled steri […]
IVTEAM

%d bloggers like this:

Share this:

Like this:

Related

Leave a Reply Cancel reply